MedTrace Logo

Clot Formation and Clot Stability in Patients With Severe Haemophilia A

NCT00279578 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2006-11-16

No results posted yet for this study

Summary

In the present study we are examining the clot formation and clot stability in patients with severe haemophilia A after they receive recombinat factor VIII and after addition of tranexamic acid. Our hypothesis is that addition of tranexamic increases the clot stability. The perpective of the study is to document whether it is relevant to use traneksamic acid in surgery in patients with severe haemophilia A.

Conditions

Interventions

DRUG

ReFacto (Recombinant factor VIII) and Tranexamic acid

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Anne-Mette Hvas, MD, Ph.D. · Aarhus University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Completion
2006-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00279578 on ClinicalTrials.gov